Anti-inflammatory molecule shows potential against Parkinson's in murine study

Article excerpt

Researchers at Brazil's Federal University of São Paulo have identified an anti-inflammatory molecule that protected brain cells in mice with Parkinson's-like symptoms, according to findings published in Neuropharmacology. The discovery offers a potential new strategy for shielding neurons from degeneration. While the work remains in early stages, tested only in animal models, it suggests a possible path toward future treatments for the neurodegenerative disease. The team's approach targets inflammation, a known driver of neuronal damage in Parkinson's.